<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Y</submitter><funding>Joint Funds for the Innovation of Science and Technology, Fujian Province</funding><funding>Guangdong Basic and Applied Basic Research Foundation Key Project</funding><funding>Science and Technology Special Fund of Guangdong Province of China</funding><funding>the National Natural Science Foundation of China youth science fund projects</funding><pagination>51</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11969778</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(1)</volume><pubmed_abstract>Neoadjuvant checkpoint blockade immunotherapy (NATI) significantly prolonged outcomes for triple-negative breast cancer (TNBC). Residual tumor cells that survive NATI represent high-risk cell populations with metastatic potential and usually evade immunosurveillance by NK cells. Using an 82-protein panel, we here profiled single-cell membrane proteomics of CD56+ (NCAM1+) NK cells from tumor, peri-cancerous tissue, as well as peripheral blood from 28 TNBC patients post-NATI of residual cancer burden II/III. Unsupervised clustering resulted in several distinct clusters: 2 tumor-infiltrating NK (TINK) clusters with divergent functions of immune activation (TNFRSF7+) and suppression (SELL+); 2 immuno-suppressive peri-cancerous clusters; and 1 periphery-specific cluster. Considering the contrad</pubmed_abstract><journal>Breast cancer research : BCR</journal><pubmed_title>Phenotypes and cytokines of NK cells in triple-negative breast cancer resistant to checkpoint blockade immunotherapy.</pubmed_title><pmcid>PMC11969778</pmcid><funding_grant_id>2023Y9054</funding_grant_id><funding_grant_id>2023B1515230004</funding_grant_id><funding_grant_id>STKJ2023002</funding_grant_id><funding_grant_id>82102687</funding_grant_id><pubmed_authors>Ding F</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Lyu X</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Chen B</pubmed_authors><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Zhu P</pubmed_authors><pubmed_authors>Huang T</pubmed_authors><pubmed_authors>Zheng H</pubmed_authors><pubmed_authors>He T</pubmed_authors><pubmed_authors>Qi X</pubmed_authors><pubmed_authors>Lu J</pubmed_authors><pubmed_authors>Niu YS</pubmed_authors><pubmed_authors>Zeng J</pubmed_authors><pubmed_authors>Zhong G</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Lin J</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phenotypes and cytokines of NK cells in triple-negative breast cancer resistant to checkpoint blockade immunotherapy.</name><description>Neoadjuvant checkpoint blockade immunotherapy (NATI) significantly prolonged outcomes for triple-negative breast cancer (TNBC). Residual tumor cells that survive NATI represent high-risk cell populations with metastatic potential and usually evade immunosurveillance by NK cells. Using an 82-protein panel, we here profiled single-cell membrane proteomics of CD56+ (NCAM1+) NK cells from tumor, peri-cancerous tissue, as well as peripheral blood from 28 TNBC patients post-NATI of residual cancer burden II/III. Unsupervised clustering resulted in several distinct clusters: 2 tumor-infiltrating NK (TINK) clusters with divergent functions of immune activation (TNFRSF7+) and suppression (SELL+); 2 immuno-suppressive peri-cancerous clusters; and 1 periphery-specific cluster. Considering the contrad</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-07-01T03:05:23.164Z</modification><creation>2025-07-01T03:05:23.164Z</creation></dates><accession>S-EPMC11969778</accession><cross_references><pubmed>40181426</pubmed><doi>10.1186/s13058-025-02003-y</doi></cross_references></HashMap>